Physician profile
Jose E Najera
NPI 1760667851
$15,155.65
in general payments reported to CMS, 2019-2025
77 companies · $1,890 in 2025
The $1,890 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,043 · 2020: $1,234 · 2021: $2,000 · 2022: $2,659 · 2023: $2,686 · 2024: $2,644 · 2025: $1,890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,682 · Education: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,682.25 |
| Education | $537.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,297.17 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,278.50 | 2019-2025 | Enhertu, Imfinzi, Lynparza |
| Novartis Pharmaceuticals Corporation | $1,145.29 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $813.69 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Amgen INC. | $652.93 | 2019-2023 | Lumakras, Blincyto, Kyprolis |
| Genentech USA, INC. | $598.51 | 2019-2025 | Polivy, Lunsumio, Itovebi |
| Astellas Pharma US INC | $514.85 | 2019-2025 | Xospata, Vyloy, Padcev |
| Genzyme Corporation | $457.24 | 2019-2025 | |
| Abbvie INC. | $431.18 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $419.39 | 2019-2025 | Opdivo, Eliquis |
| Takeda Pharmaceuticals U.S.A., INC. | $392.69 | 2019-2025 | Iclusig, Ninlaro, Alunbrig |
| Janssen Biotech, INC. | $335.58 | 2019-2025 | Rybrevant, Darzalex, Carvykti |
| Celgene Corporation | $333.39 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Incyte Corporation | $323.76 | 2019-2025 | Jakafi, Monjuvi |
| Gilead Sciences, INC. | $294.46 | 2019-2025 | Trodelvy |
Show all 77 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $285.46 | 2020-2025 | Enhertu |
| Regeneron Healthcare Solutions, INC. | $284.67 | 2019-2025 | Libtayo |
| Lilly USA, LLC | $266.37 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Eisai INC. | $256.01 | 2019-2024 | |
| Array Biopharma INC | $253.07 | 2019-2025 | Mektovi, Braftovi, Lorbrena |
| Seagen INC. | $252.04 | 2020-2023 | Adcetris, Tukysa, Padcev |
| Myriad Genetic Laboratories, INC. | $244.22 | 2021-2023 | Myrisk |
| Glaxosmithkline, LLC. | $216.71 | 2020-2025 | Zejula, Jemperli, Ojjaara |
| Boehringer Ingelheim Pharmaceuticals, INC. | $214.42 | 2019-2024 | Gilotrif |
| Alexion Pharmaceuticals, INC. | $192.58 | 2021-2025 | Ultomiris |
| Pharmacyclics LLC, An Abbvie Company | $184.73 | 2019-2023 | Imbruvica |
| Emd Serono, INC. | $177.73 | 2019-2024 | Bavencio |
| Puma Biotechnology, INC. | $170.96 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $166.85 | 2019-2024 | |
| Sobi, INC | $155.32 | 2022-2025 | |
| Beigene USA, INC. | $152.59 | 2020-2024 | Brukinsa, Tevimbra |
| Adc Therapeutics America, INC. | $139.58 | 2022-2025 | |
| Kite Pharma, INC. | $137.68 | 2020-2022 | |
| Rigel Pharmaceuticals, INC. | $135.33 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Pharmacosmos Therapeutics INC. | $132.64 | 2021-2025 | Monoferric |
| Exelixis INC. | $118.84 | 2019-2023 | Cabometyx |
| Karyopharm Therapeutics INC. | $107.12 | 2021-2024 | Xpovio |
| Aveo Pharmaceuticals, INC. | $103.99 | 2021-2025 | Fotivda |
| Ipsen Biopharmaceuticals, INC | $102.57 | 2020-2025 | Onivyde, Somatuline Depot, Tazverik |
| Lundbeck LLC | $96.78 | 2023-2025 | Rexulti |
| Taiho Oncology, INC. | $93.98 | 2019-2023 | |
| Blueprint Medicines Corporation | $86.26 | 2020-2024 | Ayvakit |
| Mirati Therapeutics, INC. | $78.06 | 2023 | Krazati |
| Sumitomo Pharma America, INC. | $58.33 | 2023-2025 | Orgovyx |
| Myovant Sciences INC. | $57.62 | 2021-2022 | |
| Stemline Therapeutics INC. | $56.15 | 2023-2025 | Orserdu |
| Beone Medicines USA, INC. | $54.40 | 2025 | Brukinsa, Tevimbra |
| Verastem, INC. | $48.66 | 2019 | |
| Apellis Pharmaceuticals, INC. | $42.78 | 2023-2024 | Empaveli |
| Morphosys, US INC. | $42.04 | 2022-2023 | Monjuvi |
| Coherus Oncology, INC. | $40.78 | 2020-2021 | |
| Tersera Therapeutics LLC | $40.36 | 2019-2023 | Zoladex |
| Acrotech Biopharma INC. | $39.83 | 2022 | |
| Tesaro, INC. | $38.94 | 2019 | |
| Geron Corporation | $38.72 | 2024-2025 | Rytelo |
| Clovis Oncology, INC. | $37.75 | 2019 | |
| Menarini Silicon Biosystems, INC. | $33.08 | 2024-2025 | |
| Epizyme, INC. | $30.37 | 2021 | |
| Fennec Pharmaceuticals, INC. | $30.23 | 2024 | Pedmark |
| Sun Pharmaceutical Industries INC. | $30.03 | 2022 | |
| Cti Biopharma Corp. | $29.20 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $29.11 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $28.45 | 2020-2022 | |
| Kerecis Limited | $24.49 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Genmab U.S., INC. | $24.00 | 2023 | Epkinly |
| Ge Healthcare | $21.92 | 2022 | |
| Dendreon Pharmaceuticals LLC | $21.41 | 2025 | Provenge |
| Novocure INC. | $21.19 | 2020 | |
| G1 Therapeutics, INC. | $19.57 | 2023 | Cosela |
| Foundation Medicine, INC. | $18.01 | 2023 | |
| Boston Scientific Corporation | $16.73 | 2019 | |
| Sirtex Medical INC | $16.67 | 2023 | Sir-Spheres Microspheres |
| Dova Pharmaceuticals | $15.41 | 2020 | |
| Jazz Pharmaceuticals INC. | $14.20 | 2024 | |
| Fortovia Therapeutics, INC. | $13.64 | 2019 | |
| Teleflex LLC | $13.29 | 2023 | Arrow |
| Blue Earth Diagnostics | $13.10 | 2022 |
Drugs and devices associated with these payments
Ibrance $580Keytruda $310Enhertu $259Kisqali $224Myrisk $171Venclexta $155Mektovi $146Braftovi $146Lynparza $144Adcetris $143Libtayo $141Xtandi $140Opdivo $139Sarclisa $138Doptelet $137Ultomiris $131Jaypirca $131Lorbrena $130Xalkori $130Imbruvica $127Brukinsa $119Pluvicto $118Jakafi $116Epkinly $114Imfinzi $114Padcev $109Tukysa $106Polivy $98.65Kerecis Omega3 Marigen $97.96Rexulti $96.78Verzenio $95.22Rybrevant $90.08Lenvima $90.07Monoferric $85.96Lunsumio $79.66Orgovyx $79.17Gilotrif $78.52Krazati $78.06Bavencio $77.44Iclusig $74.97Elrexfio $73.17Piqray $71.05Scemblix $70.75Jemperli $69.35Zejula $69.35Ninlaro $69.29Inlyta $68.76Bosulif $66.67Onivyde $65.50Alunbrig $64.21Itovebi $63.35Xospata $62.58Ojjaara $62.09Stivarga $60.82Fotivda $59.67Tevimbra $59.21Columvi $57.58Vyloy $57.47Trodelvy $56.79Orserdu $56.15Tavalisse $52.19Rezlidhia $52.19Enjaymo $49.34Cablivi $49.34Lumakras $48.85Reblozyl $48.13Darzalex $47.81Nubeqa $47.09Carvykti $43.38Empaveli $42.78Xpovio $41.89Rytelo $38.72Altuviiio $36.50Monjuvi $36.50Alprolix $36.50Pomalyst $34.49Cellsearch $33.08Talzenna $32.87Tecentriq $32.14Tecvayli $30.91Pedmark $30.23Welireg $27.35Paxlovid $26.63Kyprolis $25.18Blincyto $25.18Cabometyx $24.71Kerecis Omega3 Surgiclose $24.49Fruzaqla $23.98Promacta $23.62Nerlynx $23.40Provenge $21.41Elitek $21.38Zoladex $21.07Somatuline Depot $20.34Cosela $19.57Oxbryta $19.42Eliquis $19.13Tasigna $19.10Lutathera $18.83Retevmo $18.73
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Najera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.